Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Genetics and Genomics

A Guide to Direct-to-Consumer Genetic Tests for Cancer
Your personal genomics are a test kit away. Hear from a cancer genetic counselor on how to choose an at-home genetic test and what to expect from the results. Read More ›

Retevmo Approved for Advanced Solid Tumors with RET Fusion

Understanding Personalized Medicine and Genetics in Cancer: Why This Matters to Patients
Sometimes we hear words that sound familiar but we don’t fully know their meaning. This article explains the common terms “personalized medicine” and “targeted therapy” used by oncologists, and why we need to understand them. Read More ›

Precision Medicine Might Have Made a Difference for My Mom: It Could Help Patients with Cancer Today
After losing her mom to stage IV squamous-cell carcinoma, Kerry Cooke is now focusing on helping other patients with cancer, explaining the benefits of CureMatch, a new artificial intelligence technology that can determine the best treatment for individual patients with cancer. Read More ›

Family Matters: What a Breast Cancer Diagnosis Means for Your Loved Ones

Advances in the Treatment of Patients with NSCLC and Genetic Mutations or with Small-Cell Lung Cancer
Although most of the drugs being developed for lung cancer these days are for non–small-cell lung cancer (NSCLC), there may be a shift on the horizon as new treatment options emerge for patients with small-cell lung cancer. Read More ›

New Study Shows Causes of Lung Cancer in People Who Never Smoked
It has become increasingly clear that lung cancer can be caused by different factors, including some environmental chemicals. Lung cancer in never smokers under the microscope. Read More ›

Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial
Jim Palma and John Hopper, Co-Chairs of NORD Rare Cancer Coalition, explain the difference between genetic testing and genomic profile testing, and why all patients with rare cancers should have a genomic profile done to select the best treatment for them based on potential genomic alteration. Read More ›

Biomarker Testing Is Driving the Development of New Therapies
Non-Hodgkin lymphoma survivor Dan Dean spoke with several experts about the advances in genomic testing, which have enabled oncologists to treat patients with new “targeted therapies” that fight cancer based on the specific features of a tumor. Read More ›

Molecular Profiling and Immunotherapy Offered Me New Hope After Stage IV Lung Cancer Diagnosis
Christie Bevington shares her story of how immunotherapy was the only treatment that helped stop her cancer progression and relieve her back pain caused by lung cancer. Read More ›

Page 1 of 4